Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NOW | Employee Stock Option (Right to Buy) | Award | $48.4M | +69.4K | +33.33% | $697.76 | 278K | Nov 5, 2024 | Common Stock | 69.4K | $697.76 | Direct | F1 |
Id | Content |
---|---|
F1 | As the Issuer has previously disclosed, on October 29, 2021, a Performance Stock Option (PSO) was granted to the Reporting Person. The Issuer also disclosed that there are eight separate tranches to the PSO and any tranche may vest only if both subscription revenue and stock price performance metrics are met, in addition to service requirements. The performance period ends September 30, 2026. On November 5, 2024, the Issuer's Compensation Committee certified achievement of the subscription revenue metric for Tranche Four of the PSO. Despite having met this performance metric, the shares for Tranche Four have not yet vested. They may vest, if at all, only if: (i) the achievement of the applicable stock price metric is certified; and (ii) the Reporting Person is either Chief Executive Officer or Executive Chairman of the Issuer on such vesting date. As of November 5, 2024, 138,768 of the options are fully vested and remain exercisable. |